Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-067380

Chief Technology Officer bought 11.52 shares at $43.39 ($500)

From the SEC's structured data for this filing

Trades in this filing

HANLY ANN M. · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-29 Purchase : show line 1 in the form +11.52 $43.39 $500 11.52 I
Open-market purchases · 11.52 sh · avg $43.39 · $500
Loading xslF345X03/doc4.xml…